249 related articles for article (PubMed ID: 21462239)
1. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
[TBL] [Abstract][Full Text] [Related]
2. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
[TBL] [Abstract][Full Text] [Related]
3. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
5. A case report of the efficacy of apheresis for refractory autoimmune thrombocytopenia in a patient with systemic lupus erythematosus associated hemolytic anemia.
Yamaji K; Tsuda H; Hashimoto H
Ther Apher Dial; 2004 Jun; 8(3):227-31. PubMed ID: 15154876
[TBL] [Abstract][Full Text] [Related]
6. Double filtration plasmapheresis in a patient with autoimmune hepatitis-systemic lupus erythematosus overlap.
Suzuki K; Matsuki Y; Hidaka T; Kawaguchi Y; Kawakami M; Hino K; Nakamura H
Intern Med; 1993 Sep; 32(9):725-9. PubMed ID: 8142679
[TBL] [Abstract][Full Text] [Related]
7. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis.
Dong J; Huang L; Li C; Wu B; Yang X; Ge Y
Lupus; 2023 Aug; 32(9):1066-1074. PubMed ID: 37487569
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
10. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus. Case report and literature review from the plasmapheresis era.
Stricker RB; Davis JA; Gershow J; Yamamoto KS; Kiprov DD
J Rheumatol; 1992 Sep; 19(9):1469-73. PubMed ID: 1433019
[TBL] [Abstract][Full Text] [Related]
12. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
13. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
[TBL] [Abstract][Full Text] [Related]
14. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of thyroid dysfunction in systemic lupus erythematosus.
Appenzeller S; Pallone AT; Natalin RA; Costallat LT
J Clin Rheumatol; 2009 Apr; 15(3):117-9. PubMed ID: 19300286
[TBL] [Abstract][Full Text] [Related]
16. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
Aringer M; Smolen JS; Graninger WB
Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568
[TBL] [Abstract][Full Text] [Related]
17. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
18. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery.
Stagnaro-Green A; Akhter E; Yim C; Davies TF; Magder L; Petri M
Lupus; 2011 Jun; 20(7):690-9. PubMed ID: 21436215
[TBL] [Abstract][Full Text] [Related]
19. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
